Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits provides a comprehensive, multidisciplinary overview of the environmental, economic, and regulatory implications of advances in marine biotechnology. The book has been specifically designed to bridge the gap between the rapidly advancing marine biotechnology industry and the government agencies that are responsible for risk assessment and regulation. Editors Raymond Zilinskas and Peter Balint have brought together experts in risk assessment, marine ecology, biotechnology, economics, and the law, to provide a unique way of examining complex issues in marine biotechnology. The contributors present innovative and challenging recommendations for protecting public health and the environment, while encouraging the development of beneficial new products in the field of marine biotechnology. As an added feature, each chapter includes a comprehensive, up-to-date bibliography. Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits will prove invaluable to students, researchers and public employees involved with risk assessment. The book will appeal to industry personnel involved with the preparation of marine biotechnology products; scientists and administrators involved with applied research in marine biotechnology; policy analysts concerned with the economics of marine fisheries; and university personnel who focus on the interaction of risk, technology, and public policy.

Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits provides a comprehensive, multidisciplinary overview of the environmental, economic, and regulatory implications of advances in marine biotechnology. The book has been specifically designed to bridge the gap between the rapidly advancing marine biotechnology industry and the government agencies that are responsible for risk assessment and regulation. Editors Raymond Zilinskas and Peter Balint have brought together experts in risk assessment, marine ecology, biotechnology, economics, and the law, to provide a unique way of examining complex issues in marine biotechnology. The contributors present innovative and challenging recommendations for protecting public health and the environment, while encouraging the development of beneficial new products in the field of marine biotechnology. As an added feature, each chapter includes a comprehensive, up-to-date bibliography. Genetically Engineered Marine Organisms: Environmental and Economic Risks and Benefits will prove invaluable to students, researchers and public employees involved with risk assessment. The book will appeal to industry personnel involved with the preparation of marine biotechnology products; scientists and administrators involved with applied research in marine biotechnology; policy analysts concerned with the economics of marine fisheries; and university personnel who focus on the interaction of risk, technology, and public policy.

Zilinskas and Balint and their contributors examine the divisions between minority groups and the scientific community, particularly in the area of medical and genetic research. Minorities have reasons to be skeptical of medical research in general and genetics research in particular. The sad history of the Tuskegee experiment, in which black men with syphilis were left untreated so that the course of the disease could be studied, undermined confidence in the ethics of medical researchers. More recently, publication of "The Bell Curve" reanimated controversy over purported genetic distinctions among the races that could have powerfully negative social implications.

In contrast, as the essays make clear, the Human Genome Project, conducted in accordance with the highest ethical standards, has the potential to make dramatic positive contributions to the health of all human beings. Members of minority communities in particular--who statistically are at high risk of adverse health outcomes in the United States--have much to gain from innovative medical diagnostics and therapies that will result from the study of human genetics. Therefore, if we are to benefit fully from this new knowledge, it is vital that the distrust, skepticism, and misconceptions relating to genetics research be overcome. This is a provocative collection for scholars, students, researchers, and community leaders involved with minority and public health issues.